Paper43178
Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].
Bradshaw J and 6 others. Br J Pharmacol, 1979. Cited by 106 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Papers, record 43178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/43178
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Furans | Major topic |
| Histamine H2 Antagonists | Major topic |
| Animals | |
| Guinea Pigs | |
| In Vitro Techniques |
Source PubMed
References1
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|---|
| 1 | 5312 | Some chemical aspects of histamine H2-receptor antagonists. | Fed Proc | 1976 | https://conductscience.org/library/papers/5312 |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35409346 | Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409346 | PubMed |
| 32397705 | Development of a Conformational Histamine H3 Receptor Biosensor for the Synchronous Screening of Agonists and Inverse Agonists. | ACS Sens | 2020 | https://conductscience.org/library/papers/32397705 | PubMed |
| 30341770 | Histamine pharmacology: from Sir Henry Dale to the 21st century. | Br J Pharmacol | 2020 | https://conductscience.org/library/papers/30341770 | PubMed |
| 22994263 | Sir David Jack: an extraordinary drug discoverer and developer. | Br J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/22994263 | PubMed |
| 16402096 | Histamine and its receptors. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16402096 | PubMed |
| 7647984 | JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7647984 | PubMed |
| 6277357 | Ranitidine delays gastric emptying of solids in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6277357 | PubMed |
| 6182771 | A species comparison of the histamine H2-receptor on mast cells and basophils. | Agents Actions | 1982 | https://conductscience.org/library/papers/6182771 | PubMed |
| 6152891 | H2 receptor antagonists and anaesthesia. | Can Anaesth Soc J | 1983 | https://conductscience.org/library/papers/6152891 | PubMed |
| 6141898 | Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients. | Dig Dis Sci | 1984 | https://conductscience.org/library/papers/6141898 | PubMed |
| 6130963 | Impaired TSH response to TRH after intravenous ranitidine in man. | Experientia | 1983 | https://conductscience.org/library/papers/6130963 | PubMed |
| 6128216 | Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. | Drugs | 1982 | https://conductscience.org/library/papers/6128216 | PubMed |
| 6127150 | Comparative trial of the effect of ranitidine and cimetidine on gastric secretion in fasting patients at induction of anaesthesia. | Can Anaesth Soc J | 1982 | https://conductscience.org/library/papers/6127150 | PubMed |
| 6125203 | Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125203 | PubMed |
| 6123238 | Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine. | Agents Actions | 1982 | https://conductscience.org/library/papers/6123238 | PubMed |
| 6121599 | Inhibition by the tetramine disulphide, benextramine, of cardiac chronotropic histamine H2-receptor-mediated effects. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/6121599 | PubMed |
| 6119622 | Effect of some new Histamine H2-receptor antagonists on the guinea-pig papillary muscle. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/6119622 | PubMed |
| 6117305 | Pharmacokinetics of the H2- receptor antagonist ranitidine in man. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6117305 | PubMed |
| 6113921 | Mesenteric vascular reactivity to histamine receptor agonists and antagonists. | Dig Dis Sci | 1981 | https://conductscience.org/library/papers/6113921 | PubMed |
| 6113744 | H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat. | Agents Actions | 1981 | https://conductscience.org/library/papers/6113744 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HRH2 | 3274 | PubTator's text mining | https://conductscience.org/library/genes/3274 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/43178
GET https://conductscience.org/api/papers/v1/43178/cited_by?page=2